Page 2 - Tim Etheridge News Today

Led by scientists from Nottingham and Exeter University, with hardware designed by Oxford-based Kayser Space, a research team aims to determine the...

The worms will launch from the Kennedy Space Centre to help UK researchers understand muscle loss.

Thousands of tiny worms will be launched into space this week (3 June) to help scientists to understand more about muscle loss and how to prevent it. Led...

WiredGov Newswire (news from other organisations) UK Space Agency - Worms on a mission to research muscle loss in space Today (Thursday 3rd June), hundreds of tiny worms are being flown to the International Space Station (ISS) as part of an experiment to understand more about human muscle loss and how to prevent it. Funded by the UK Space Agency, a team of scientists led by scientists from Nottingham and Exeter University, with hardware designed by Oxford-based Kayser Space, aims to determine t...

Stimulus bill includes funds for arts venues. Which Berkeley ones will be eligible? The Save Our Stages act makes about $15 billion available to independent music venues, theaters and cultural organizations. Dark Star Orchestra playing UC Theatre in 2016. Founder David Mayeri says he doesn’t expect the venue to reopen until fall 2021. Photo: Kelly Owen As Congress rushed to pass a $900 billion stimulus package Monday night that faced immediate criticism as too little too late, many venues and...

Study paves the way to a potential new treatment for rare terminal childhood illness Scientists at the University of Exeter have identified a way to "rescue" cells that have genetically mutated, paving the way to a possible new treatment for rare terminal childhood illness such as mitochondrial disease. The research, funded by the United Mitochondrial Disease Foundation in the USA, was led by Professors Matt Whiteman and Tim Etheridge. In the study, published in the Journal of Inherited Metabo...

 E-Mail Scientists at the University of Exeter have identified a way to "rescue" cells that have genetically mutated, paving the way to a possible new treatment for rare terminal childhood illness such as mitochondrial disease. The research, funded by the United Mitochondrial Disease Foundation in the USA, was led by Professors Matt Whiteman and Tim Etheridge. In the study, published in the Journal of Inherited Metabolic Disease, the team used novel drugs being developed at the University of...